BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8674049)

  • 1. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
    Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
    Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
    Niinaka Y; Paku S; Haga A; Watanabe H; Raz A
    Cancer Res; 1998 Jun; 58(12):2667-74. PubMed ID: 9635595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
    Tanaka N; Haga A; Naba N; Shiraiwa K; Kusakabe Y; Hashimoto K; Funasaka T; Nagase H; Raz A; Nakamura KT
    J Mol Biol; 2006 Feb; 356(2):312-24. PubMed ID: 16375918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
    Tanaka N; Haga A; Uemura H; Akiyama H; Funasaka T; Nagase H; Raz A; Nakamura KT
    J Mol Biol; 2002 May; 318(4):985-97. PubMed ID: 12054796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
    Lagana A; Duchaine T; Raz A; DesGroseillers L; Nabi IR
    Biochem Biophys Res Commun; 2000 Jun; 273(1):213-8. PubMed ID: 10873589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of B16-F1 melanoma autocrine motility factor and its receptor.
    Silletti S; Watanabe H; Hogan V; Nabi IR; Raz A
    Cancer Res; 1991 Jul; 51(13):3507-11. PubMed ID: 1647268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.
    Chaput M; Claes V; Portetelle D; Cludts I; Cravador A; Burny A; Gras H; Tartar A
    Nature; 1988 Mar; 332(6163):454-5. PubMed ID: 3352744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
    Tsutsumi S; Hogan V; Nabi IR; Raz A
    Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heregulin regulation of autocrine motility factor expression in human tumor cells.
    Talukder AH; Adam L; Raz A; Kumar R
    Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
    Dobashi Y; Watanabe H; Matsubara M; Yanagawa T; Raz A; Shimamiya T; Ooi A
    J Pathol; 2006 Jan; 208(1):44-53. PubMed ID: 16294294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate.
    Lagana A; Goetz JG; Y N; Altschuler Y; Nabi IR
    J Cell Sci; 2005 Sep; 118(Pt 18):4175-85. PubMed ID: 16141236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns in mouse embryos of neuroleukin/glucose-6-phosphate isomerase and autocrine motility factor receptor.
    Repiso A; Andrés R; Climent F; Ureña JM
    Anat Histol Embryol; 2008 Oct; 37(5):380-2. PubMed ID: 18537943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
    Haga A; Niinaka Y; Raz A
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):235-44. PubMed ID: 11004567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
    Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
    Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
    Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
    Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin.
    Baumann M; Brand K
    Cancer Res; 1988 Dec; 48(24 Pt 1):7018-21. PubMed ID: 3191476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
    Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
    Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences.
    Faik P; Walker JI; Redmill AA; Morgan MJ
    Nature; 1988 Mar; 332(6163):455-7. PubMed ID: 3352745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.